Antiplatelet Drugs-a New Pharmacologic Approach to the Prevention of Thrombosis
Overview
Authors
Affiliations
Ramirez J, Alarabi A, Khasawneh F, Alshbool F Int J Mol Sci. 2022; 23(15).
PMID: 35955928 PMC: 9369033. DOI: 10.3390/ijms23158794.
Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim Z, Vemana H, Alshbool F, Lin O, Alshehri A, Javaherizadeh P Arterioscler Thromb Vasc Biol. 2015; 35(3):637-44.
PMID: 25593131 PMC: 4344398. DOI: 10.1161/ATVBAHA.114.304509.
Viinikka L, Ylikorkala O Br J Pharmacol. 1981; 72(2):299-303.
PMID: 7011467 PMC: 2071515. DOI: 10.1111/j.1476-5381.1981.tb09129.x.
Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.
Margulies E, White A, Sherry S Drugs. 1980; 20(3):179-97.
PMID: 7000488 DOI: 10.2165/00003495-198020030-00002.
The effect of antiaggregating drugs on the patency of grafts in the arterial system.
Pirk J, Ruzbarsky V, Konig J, Krajicek M, Pavel P, FIRT P World J Surg. 1980; 4(5):615-9.
PMID: 6894509 DOI: 10.1007/BF02401646.